# Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas

> **NCT02613988** · NA · RECRUITING · sponsor: **Asan Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Adult Glioblastoma

## Interventions

- **DEVICE:** 3 Tesla magnetic resonance imaging
- **DEVICE:** Chemical exchange saturation transfer MRI
- **DEVICE:** Diffusion weighted MRI
- **DEVICE:** Dynamic susceptibility contrast MRI

## Key facts

- **NCT ID:** NCT02613988
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-12
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02613988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02613988, "Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02613988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*